Supernus Pharmaceuticals (SUPN)
(Delayed Data from NSDQ)
$29.10 USD
-0.06 (-0.21%)
Updated May 17, 2024 04:00 PM ET
After-Market: $29.05 -0.05 (-0.17%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Revenue - Line of Business Segments | YR Estimate | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|---|
Revenues: Net product sales [$M] |
-- | 574 | 649 | 568 | 509 | 383 |
Revenues: Royalty revenues [$M] |
-- | 34 | 18 | 12 | 11 | 9 |
Revenues: Net product sales: Qelb... |
-- | 140 | 61 | 10 | -- | -- |
Revenues: Net product sales: GOCO... |
-- | 120 | 104 | 10 | -- | -- |
Revenues: Net product sales: Oxte... |
-- | 113 | 115 | 111 | 99 | -- |
Revenues: Net product sales: Trok... |
-- | 94 | 261 | 305 | 320 | -- |
Revenues: Net product sales: APOK... |
-- | 75 | 75 | 99 | 74 | -- |
Revenues: Net product sales: Othe... |
-- | 31 | 32 | 33 | 17 | -- |